Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | SOLV | RVTY | ||
| Company | Charles River Laboratories | Solventum Corporation | Revvity Inc | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 280.06 | 86.14 | 116.51 | ||
| High | 283.20 | 89.48 | 117.72 | ||
| Low | 276.66 | 85.29 | 115.66 | ||
| Last | 280.05 | 88.59 | 116.84 | ||
| Change | -1.22 | +2.13 | -0.66 | ||
| Percent Change | -0.43% | +2.46% | -0.56% | ||
| Volume | 750,300 | 1,450,400 | 774,500 | ||
| 20-Day Average Volume | 955,675 | 1,245,125 | 1,571,710 | ||
| Previous | 281.27 | 86.46 | 117.50 | ||
| Industry | Medical Services | Medical Services | Medical Services | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 247.19 | 83.86 | 113.23 | ||
| 20-Day Raw Stochastic | 89.32% | 89.34% | 90.61% | ||
| 20-Day Relative Strength | 73.89 | 61.68 | 58.94 | ||
| Weighted Alpha | +96.94 | +29.40 | +34.02 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.70% since 08/07/26 | +6.76% since 08/07/26 | +1.90% since 08/07/26 | ||
| Low | 265.49 on 08/10/26 | 81.76 on 08/10/26 | 112.68 on 08/10/26 | ||
| High | 288.02 on 08/12/26 | 89.48 on 08/14/26 | 118.34 on 08/13/26 | ||
| 1-Month | |||||
| %Chg | +21.12% since 07/14/26 | +16.14% since 07/14/26 | +5.06% since 07/14/26 | ||
| Low | 213.40 on 07/21/26 | 75.69 on 07/15/26 | 102.36 on 07/21/26 | ||
| High | 288.02 on 08/12/26 | 90.00 on 08/06/26 | 118.34 on 08/13/26 | ||
| 3-Month | |||||
| %Chg | +76.00% since 05/14/26 | +19.04% since 05/14/26 | +21.23% since 05/14/26 | ||
| Low | 146.20 on 05/19/26 | 72.74 on 05/20/26 | 92.97 on 05/21/26 | ||
| High | 288.02 on 08/12/26 | 90.00 on 08/06/26 | 118.34 on 08/13/26 | ||
| 6-Month | |||||
| %Chg | +73.57% since 02/13/26 | +17.26% since 02/13/26 | +21.67% since 02/13/26 | ||
| Low | 146.20 on 05/19/26 | 62.38 on 04/07/26 | 81.22 on 04/29/26 | ||
| High | 288.02 on 08/12/26 | 90.00 on 08/06/26 | 118.34 on 08/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 13,369,304 | 15,080,142 | 13,037,706 | ||
| Shares Outstanding, K | 47,739 | 170,224 | 111,586 | ||
| Annual Sales, $M | 4,015,380,000 | 8,325,000,000 | 2,856,050,000 | ||
| Annual Net Income, $M | -144,340,000 | 1,556,000,000 | 241,200,000 | ||
| Last Qtr Sales, $M | 1,004,080,000 | 2,209,000,000 | 729,690,000 | ||
| Last Qtr Income, $M | -1,480,000 | 93,000,000 | 51,820,000 | ||
| 60-Month Beta | 1.38 | 0.60 | 1.07 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.02 on 08/05/26 | 2.55 on 08/05/26 | 1.41 on 08/04/26 | ||
| Latest Earnings Date | 11/04/26 | 11/05/26 | 10/26/26 | ||
| Most Recent Dividend | N/A | N/A | 0.070 on 07/17/26 | ||
| Next Ex-Dividend Date | N/A | N/A | 10/23/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 28.41 | 12.18 | 21.96 | ||